Instalab

CAC Score LM Test

Your sharpest read on whether the most dangerous coronary artery is quietly hardening, beyond what total calcium scoring alone can tell you.

Should you take a CAC Score LM test?

This test is most useful if any of these apply to you.

Worried About Your Heart Health
If heart disease runs in your family or your risk feels uncertain, this scan shows whether the most critical artery is silently hardening.
Already Tracking Your Calcium Score
If you have had a calcium scan, knowing how much sits specifically in the left main reframes what your overall number really means for your risk.
Living With Diabetes or Metabolic Disease
Diabetes plus heavy left main calcification carries risk equivalent to having already had a heart attack, making this a high-yield read for you.
Healthy but Want to Stay Ahead
If your standard labs look normal but you want a real look at your arteries, this is one of the few tools that reveals silent disease before symptoms appear.

About CAC Score LM

The left main coronary artery is the single most important blood vessel in your heart. It feeds about two thirds of the heart muscle, and a serious blockage there can cause a massive heart attack or sudden death. The left main calcium score isolates how much calcified plaque has built up in this one critical artery, separate from the rest of your coronary tree.

Most people who get a cardiac calcium scan focus only on the total number, but the location of the calcium matters. A high overall score driven mostly by left main calcium tells a different story than the same score spread across smaller branches. This vessel-specific reading helps you understand whether the riskiest real estate in your heart is involved.

What This Score Actually Measures

Your left main CAC (coronary artery calcium) score comes from a quick, non-contrast cardiac CT scan. The scanner spots tiny mineral deposits in the artery wall and a computer calculates the Agatston score, which combines the area covered by calcium with how dense it is. The result is reported in Agatston units, broken out by vessel.

Calcium in a coronary artery is the body's footprint of long-running atherosclerosis (the slow buildup of fatty plaque that can harden over time). It does not measure soft, uncalcified plaque, which is why a low number does not always mean a perfectly clean artery, especially in younger adults.

Why Left Main Involvement Matters So Much

In a study of 2,246 asymptomatic adults with very high overall calcium scores (above 1,000), severe left main calcification, defined as a left main score of 300 or higher, roughly doubled the risk of dying from cardiovascular disease compared with people who had similarly high total scores but less left main involvement. The risk was independent of the total calcium burden and traditional risk factors. When severe left main calcium and diabetes appeared together, the resulting risk matched that of people who already had a prior heart attack or stroke.

What this means for you: a high left main score does not just add to your overall risk picture. It can reframe it. Two people with identical total calcium scores can sit in very different risk tiers depending on whether the left main is involved.

Heart Attack and Coronary Disease Risk

The broader research on coronary calcium consistently shows that more calcium means more risk. Each doubling of total CAC is linked to about 14% higher risk of atherosclerotic cardiovascular events, independent of standard risk factors. Symptomatic patients with any calcium present have substantially higher rates of major adverse cardiac events compared with those scoring zero.

Left main involvement specifically is treated as a marker of advanced, high-stakes disease. In multinational registry data, total scores above 300 produced cardiovascular event rates equivalent to people who already had established cardiovascular disease, supporting an aggressive prevention approach.

Stroke, Heart Failure, and Death

Higher coronary calcium is linked to a graded increase in stroke, heart failure hospitalization, the need for procedures like stenting or bypass, and all-cause death. In a cohort of 23,637 adults followed long-term, calcium scoring meaningfully improved prediction of major adverse events and mortality even in younger, low-risk adults.

In adults aged 32 to 46, having any detectable coronary calcium raised the risk of clinical heart disease, cardiovascular disease, and death. A score of 100 or more in this age group was associated with early mortality. The implication for your left main reading: any visible calcium in this vessel before midlife is a meaningful early signal, not background noise.

Reference Ranges

There are no standardized clinical cutpoints specifically for left main calcium alone. The thresholds below come from the largest research cohort to study left main involvement directly, in adults whose total calcium score was already very high (above 1,000). They are useful orientation, not universal targets, and your scan center may report values differently.

TierLeft Main Score (Agatston Units)What It Suggests
None or minimal0No detectable calcium in the left main artery
Mild to moderate1 to 299Some left main calcification present, lower-risk pattern in the high-CAC population studied
Severe300 or higherHeavily calcified left main, roughly doubled cardiovascular mortality risk in adults with very high total scores

Source: Razavi et al. Compare your results within the same imaging center over time for the most meaningful trend, since scanner technology and reading conventions can vary.

Tracking Your Trend

A single reading is a snapshot. The full picture comes from watching how your number behaves over years. Calcium scores generally rise with age and progression of atherosclerosis, but the rate of change carries information. Slow progression on top of preventive therapy often reflects plaque stabilization, while rapid progression suggests the underlying disease process is still active.

A reasonable cadence: get a baseline scan if you fit the testing criteria, retest in 3 to 5 years to track progression, and sooner if your overall risk picture has shifted significantly. People starting aggressive lipid-lowering therapy may see calcium scores rise even as event risk falls, which is why interpretation must consider treatment status.

Reconciling the Statin Paradox

Here is something that confuses many people: long-term, high-dose statins can actually accelerate measured calcium scores, including in the left main, even while reducing heart attacks and deaths. This is not a contradiction. Statins shift plaque composition, converting unstable, soft plaque into denser, more calcified, more stable lesions. The number on your report goes up, but the biology underneath is moving in the right direction. This is why a rising score on statins is interpreted differently than a rising score off therapy.

When Results Can Be Misleading

Calcium scores are anatomically stable, so they do not fluctuate with meals, recent exercise, or short illnesses. But interpretation can still be thrown off by a few factors:

  • Younger age: a score of zero misses non-calcified plaque more often in adults under 45, so a zero reading does not fully rule out early disease in this group.
  • Statin therapy: long-term use can raise the calcium number while improving outcomes, so context matters when interpreting a rising score.
  • Scanner and protocol differences: vessel-specific scoring, especially in the small left main, depends on image quality and reader technique. Comparing scans done on different machines can introduce variability.
  • Imaging artifacts: motion, breathing, or image noise can occasionally cause minor calcium to be missed or overcalled, particularly in the left main due to its short length and proximity to other structures.

What to Do With an Abnormal Result

If your left main score is elevated, especially above 300 in the setting of a high total score, treat it as a strong signal to escalate prevention. Order or review the full lipid picture including ApoB (apolipoprotein B, a count of all the harmful cholesterol particles in your blood) and Lp(a) (lipoprotein little a, an inherited lipid risk factor). Check inflammatory markers like hs-CRP (high-sensitivity C-reactive protein, a marker of body-wide inflammation) and metabolic markers including HbA1c (a three-month average of blood sugar). Ask about coronary CT angiography to look at plaque composition and stenosis directly, especially if you have symptoms.

A high left main score is generally a reason to involve a preventive cardiologist or lipidologist, push lipid targets aggressively low, and consider whether you fit the profile for more intensive interventions. A score of zero across the left main and other vessels supports a lower-intensity preventive plan, though it does not eliminate the value of standard cardiovascular risk reduction.

What Moves This Biomarker

Evidence-backed interventions that affect your CAC Score LM level

Up & Down
Take a statin medication
Statins lower your risk of heart attack and death from coronary disease, but the number on your calcium scan often goes UP rather than down. In a study of 654 adults followed with serial coronary CT, statin users showed increased calcified plaque volume and slowed or reduced soft, non-calcified plaque, a pattern interpreted as plaque stabilization. In a 28,025-patient consortium, statin users still derived strong protective benefit despite higher measured calcium scores. Translation: a rising calcium score on statins reflects the medication doing its job, hardening unstable plaque into more stable lesions.
MedicationModerate Evidence
Decrease
Use a calcium-score-guided prevention strategy
When people with a family history of premature coronary disease used their calcium score to guide treatment intensity, they ended up with less plaque progression and lower atherogenic lipids than those treated without that information. In a 365-person randomized trial, the calcium-guided group had reduced lipid levels and slower plaque progression at follow-up. Knowing your number, including the left main, appears to drive better adherence and more aggressive treatment when warranted.
LifestyleModerate Evidence
Decrease
Add a PCSK9 inhibitor on top of statin therapy
Combining a PCSK9 inhibitor (a powerful injectable cholesterol-lowering drug) with a statin slowed the annual rate of coronary calcium progression compared with statin alone in a study of 151 adults with coronary artery disease. The trial focused on the combination's effect on calcium accumulation over time, suggesting that intensive lipid lowering may slow new plaque formation even on top of statin therapy.
MedicationModest Evidence
Decrease
Take aged garlic extract daily
Aged garlic extract slowed coronary calcium progression in randomized trials. In a placebo-controlled trial of 104 adults at increased cardiovascular risk, aged garlic extract reduced the rate of calcium accumulation, lowered inflammatory markers, and reduced blood pressure. An earlier 65-person trial that combined aged garlic extract with B vitamins, folic acid, and L-arginine also showed slowed progression of subclinical atherosclerosis.
SupplementModest Evidence

Frequently Asked Questions

References

14 studies
  1. Razavi AC, Shaw L, Berman D, Budoff M, Wong N, Vaccarino V, Van Assen M, De Cecco CD, Quyyumi a, Mehta a, Muntner P, Miedema M, Rozanski a, Rumberger J, Nasir K, Blumenthal R, Sperling L, Mortensen MB, Whelton S, Blaha M, Dzaye OJACC. Cardiovascular Imaging2024
  2. Greenland P, Blaha M, Budoff M, Erbel R, Watson KJournal of the American College of Cardiology2018
  3. Budoff M, Young R, Burke G, Carr JJ, Detrano R, Folsom a, Kronmal R, Lima J, Liu K, Mcclelland R, Michos E, Post W, Shea S, Watson K, Wong NEuropean Heart Journal2018
  4. Mitchell JD, Paisley R, Moon P, Novak E, Villines TJACC. Cardiovascular Imaging2017
  5. Carr JJ, Jacobs D, Terry J, Shay C, Sidney S, Liu K, Schreiner P, Lewis C, Shikany J, Reis J, Goff DJAMA Cardiology2017